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under the CC BY license (http://creatSummary Objective: To assess mortality risk among adults presenting to an African teaching
hospital with sepsis and severe sepsis in a setting of high HIV prevalence and widespread ART
uptake.
Methods: Prospective cohort study of adults (age 16 years) admitted with clinical suspicion of
severe infection between November 2008 and January 2009 to Queen Elizabeth Central Hospi-
tal, a 1250-bed government-funded hospital in Blantyre, Malawi. Demographic, clinical and
laboratory information, including blood and cerebrospinal fluid cultures were obtained on
admission.
Results: Data from 213 patients (181 with sepsis and 32 with severe sepsis; M:F Z 2:3) were
analysed. 161 (75.6%) patients were HIV-positive. Overall mortality was 22%, rising to 50%
amongst patients with severe sepsis. The mortality of all sepsis patients commenced on anti-
retroviral therapy (ART) within 90 days was 11/28 (39.3%) compared with 7/42 (16.7%) among
all sepsis patients on ART for greater than 90 days (p Z 0.050). Independent associations
with death were hypoxia (OR Z 2.4; 95% CI, 1.1e5.1) and systolic hypotension (OR 7.0; 95%
CI: 2.4e20.4).rpool-Wellcome Trust Clinical Research Programme, PO Box 30096, Chichiri, Blantyre 3, Malawi.
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12 P.I. Waitt et al.Conclusions: Sepsis and severe sepsis carry high mortality among hospitalised adults in Malawi.
Measures to reduce this, including early identification and targeted intervention in high-risk
patients, especially HIV-positive individuals recently commenced on ART, are urgently
required.
ª 2014 The Authors. Published by Elsevier Ltd on behalf of the The British Infection
Associat ion. This is an open access art icle under the CC BY l icense (http://
creativecommons.org/licenses/by/3.0/).Background
Severe sepsis is a leading non-cardiovascular cause of death
in critically ill patients worldwide, with 90% of deaths from
pneumonia, meningitis and other infections occurring in
low-resource settings. In countries such as Malawi, where
there is a high burden of HIV-related disease,1 sepsis is
thought to be a major killer. However, despite numerous
studies of microbiologically-proven bloodstream infections
(BSI) in sub-Saharan Africa (SSA),2,3 few have sought to sys-
tematically evaluate patients against internationally
defined criteria for sepsis in such settings.4
Case definitions for sepsis, severe sepsis and systemic
inflammatory response syndrome (SIRS) were developed in
19925 and with refinements in 2002,6 20087 and 2013.8 The
Surviving Sepsis Campaign, recommending ‘bundles’ of
early, specific interventions has led to demonstrable im-
provements in clinical outcomes in severe sepsis in well-
resourced settings.9 However, although early identification
and treatment of sepsis in low-income countries have been
highlighted as essential components of good clinical care by
the World Health Organisation (WHO),10 lack of data
regarding the clinical manifestations of severe sepsis from
many such countries renders it problematic to derive
evidence-based guidelines.11e13 Differences in age range,
spectrum of aetiology, and co-morbidities such as HIV, TB
and malaria makes extrapolation of data from high/
middle-income to low income countries unreliable.
Furthermore, resource limitations are a significant
constraint to implementing even simple interventions.11
This study therefore aimed to assess the risk of death
among adult medical patients presenting to hospital with
syndromically defined sepsis and severe sepsis in the
context of a low income African setting with high HIV
prevalence. Furthermore, we have investigated the impact
of ART on clinical outcomes from sepsis and severe sepsis in
this environment and sought to identify additional simple
physiological assessments that could be used to identify
high risk patients in whom interventional trials are
warranted.
Methods
Setting
Queen Elizabeth Central Hospital (QECH) is a 1250-bed
government-funded teaching hospital providing secondary
and tertiary care, free of at the point of care to the
patient. QECH serves a population of approximately one
million including the city of Blantyre, the surrounding
townships, and outlying villages. At QECH, measurementof central venous pressure, blood gas analysis and urine
output are logistically difficult and rarely performed.
Vasopressors and inotropes are unavailable on the medical
wards. High-flow oxygen from cylinders is unavailable,
therefore oxygen therapy is provided through oxygen
concentrators when available. Patients with severe sepsis
and septic shock are rarely admitted to the QECH intensive
care unit (ICU) because of high bed occupancy and
perceived futility for such patients. On the adult medical
wards, two nurses are typically responsible for between 60
and 90 patients (greater than 100% bed occupancy is
common).
Patients
Consecutive adults (age 16 years) with a clinical suspicion
of severe infection (as determined by the admitting
clinician) admitted to the Department of Adult Internal
Medicine at QECH, between November 2008 and January
2009 were prospectively recruited following informed con-
sent from the patient or their guardian. Enrolment,
assessment and follow-up were conducted by a dedicated
research team and recruitment did not take place at
weekends or outside routine working hours on weekdays
due to staffing constraints. Patients were excluded from
enrolment if they had been hospitalised or received
antibiotics in the preceding two weeks, or if it was not
possible to obtain written consent from the patient (e.g. an
obtunded patient with no guardian available). Patient
demographics, clinical and laboratory characteristics were
recorded on a standardised assessment form. Follow-up
was to hospital discharge or in-hospital death.
Case definitions
Sepsis and severe sepsis were identified using modified
standard criteria as set out in Table 1a and 1b.4,6 Due to
resource constraints, markers of severe sepsis were limited
to those which could be assessed clinically or through sim-
ple laboratory tests. Capillary refill time is recognised as a
surrogate for end tissue perfusion.14 Oxygen saturations
have been used as surrogate for partial pressure of oxygen.
Thrombocytopenia was not used as a marker of severe
sepsis in HIV-infected individuals.15,16 Tuberculosis was sus-
pected in patients who failed to respond to antibiotics for
presumed pneumonia or in whom there were suspicious
CXR changes; investigation and treatment were instigated
at the discretion of the responsible clinician in accordance
with national guidelines.17
All patients were screened for malaria, and all patients
with a positive malaria film received either oral
lumefantrine-arthemeter or intravenous quinine according
to national guidelines.
Table 1 Criteria used for the diagnosis of a) Sepsis and b)
Severe Sepsis.
a) Sepsis criteria (at least 2 present)
Temperature <35 C or >38.3 C
Respiratory rate >20 breaths/minute
Pulse >90 beats/minute
White cell count >12 or <4  109 cells/l
Altered mental state
b) Severe sepsis criteria (at least 2 sepsis criteria and
either systolic blood pressure <90 mmHg, or at least 2
severe sepsis criteria present)
Thrombocytopenia <100,000  109 cells/l (if HIV neg)a
Oxygen saturations in room air (<90% on room air)
Systolic blood pressure <90 mmHg
Reduced capillary refill (>2 s)
a Thrombocytopenia is common in HIV infected adults.
Severe sepsis in Malawian adults 13Given its unpredictability and the very low nursing
coverage available, the mode of death could not be
captured. Autopsies were not routinely available. Retro-
spective chart review was not feasible because patient
notes are frequently unavailable following discharge and do
not contain the information necessary for a study of this
nature.
Laboratory investigations
Patients had 5e10 mL of blood drawn for aerobic culture in
an automated system (BacT/ALERT, Bio-Merieux). A full
blood count (Coulter Hmx Haematology Analyzer), malaria
thick film and HIV testing using Determine HIV 1/2 kit
(Abbott Diagnostic Division) and Unigold HIV 1/2 kit
(Trinity Biotech Inc.), according to manufacturers’ instruc-
tions, were performed in all patients. Lumbar punctures
(LP) and standard CSF analysis were performed when there
was a clinical suspicion of meningitis. Identification of
blood and CSF isolates was performed using standard
methods with external quality control (United Kingdom
National External Quality Assessment Service).18e20 Coagu-
lase negative Staphylococci, Diptheroids, Micrococcus spp
and Bacillus spp other than anthracis were considered as
contaminants. Mycobacterial blood cultures were not per-
formed due to resource constraints. Additional investiga-
tions were undertaken by the responsible medical team
as considered clinically indicated. CD4 counts were not
routinely available.
Statistical analysis
Statistical analyses were performed using STATA for win-
dows software (version SE/11; 4905; Stata corp; College
Station, Texas 77845 USA). Statistical tests were performed
at 5% significance level. Descriptive analysis of baseline
variables was performed to summarize patient character-
istics. T-tests compared means of normally distributed and
ManneWhitney U tests compared medians (the distribution)
of the variables with skewed distributions respectivelybetween the sepsis and severe sepsis groups. Fisher’s exact
test was used to assess an association between a binary var-
iable and diagnosis (whether patient had sepsis or severe
sepsis), with p values of less than 0.05 considered signifi-
cant. Fisher’s exact test was preferred to the Pearson’s
Chi-square tests for associations because it has superior
statistical properties when the numbers are small as is
the case in this study. Time to event, where time was
admission duration and event was death, was modelled us-
ing survival methods such Kaplan Meier plots, log-lank tests
and the Cox proportional hazards regression models. Ka-
planeMeier (KM) survival curves were compared with the
log-rank test. Patients lost to follow-up before discharge
were censored at their last known assessment. Univariate
logistic regression identified variables associated with
outcome (death), with subsequent multivariate logistic
regression to obtain adjusted estimates. A stepwise vari-
able selection procedure was used to find independent pre-
dictors of outcome (death) with p-to-enter of 0.05 or less,
and p-to-remove of 0.15. The 95% confidences intervals
were obtained where applicable. A logistic regression was
also used to identify factors associated with sepsis.
In addition, KM curves were plotted to compare time to
death from time of admission between HIV positive and HIV
negative patients. The Cox proportional hazards regression
model was fitted to obtain the hazard ratios, 95% confi-
dence intervals (CI) and corresponding p-values. KM plots
were also plotted for the HIV subset comparing the survival
probabilities by ART status.
Ethics statement
Ethical approval for the study was prospectively obtained
from the College of Medicine Research and Ethics Commit-
tee, University of Malawi (COMREC no P.05/08/667).
Results
Patient characteristics
Two hundred and twenty nine patients fulfilled the sepsis
criteria including 32 who fulfilled the severe sepsis criteria.
This represents 18% of the 1250 patients who were
admitted to the adult medical wards during that time
period (hospital data). Informed consent could not be
obtained for 12 moribund patients who may have met
inclusion criteria, and these do not feature in subsequent
analysis. Two hundred and twenty seven were enrolled
(Fig. 1). Fourteen patients were lost to follow-up during
their inpatient stay due to premature self- or family initi-
ated discharge. Analysis was conducted on the remaining
213 (93.0%) patients (181 with sepsis and 32 with severe
sepsis). Intravenous ceftriaxone was used as empirical first
line therapy, with no differences in antibiotic usage be-
tween patients who died and survivors. No patients were
admitted with indwelling intravascular or ureteric cathe-
ters. There were no patients on treatment for chronic
renal, lung or cardiovascular disease.
Descriptive demographic, HIV and clinical characteristics
of the cohort are summarised in Table 2. The median age
was 30 years (IQR 25e39), with no significant difference
Figure 1 Patient recruitment.
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infected and of these, 70 out of the 161 HIV infected, 43.5%
were on ART. The majority of HIV-infected patients (55%)
were unaware of their HIV status prior to enrolment in
the study (this is typical for all patients admitted to these
wards). As anticipated, features of systemic inflammatory
response and impaired tissue perfusion such as pulse rate,
respiratory rate, systolic blood pressure (SBP), Glasgow
Coma Scale (GCS), capillary refill time and oxygen satura-
tion were generally more abnormal amongst the severe
sepsis compared with the sepsis patients (Table 2). The
lung (based on clinical symptoms and signs suggestive of
respiratory tract infection) was the most common focus of
presumed infection but radiological confirmation by either
X-ray or ultrasound was not always available. This wasTable 2 General demographics, HIV features and clinical chara
All patient
n Z 213
General demographics:
Sex (Female), n (%) 126 (59.2
Age (years), median (IQR) 30 (25e3
HIV features:
Number HIV infected, n (%) of HIV positive subset, 161 (75.6
Number aware of prior HIV diagnosis, n (%) 88 (54.7
Number on ART, n (%) 70 (43.5
On ART <90 days, n (%) 28 (21.7
Clinical characteristics:
Temp (

C), median (IQR)a 38.8 (38.1
Pulse rate (bpm), median (IQR)a 105 (96e1
Respiratory rate (/min),median (IQR)a 26 (22e3
SBP in mmHg, median (IQR)a 110 (100e
Glasgow Coma Scale, Mean (sd)b 14.6 (2.0)
Oxygen saturations, median (IQR)a 93 (90e9
P*-value: fisher’s exact p-value has been reported for associations be
a Man-Whitney U test was performed.
b t-test was performed.followed by sepsis of unknown source (49 patients) and
meningitis (insert numbers here) identified by lumbar punc-
ture with a raised CSF white cell count (7 patients were cul-
ture confirmed). Forty patients (18.8% of the cohort) were
clinically suspected of having tuberculosis on the basis of
the criteria described above and commenced on treatment,
microbiological confirmation was obtained in 14 (35% of TB
suspects). There were no patients in whom immune recon-
stitution inflammatory syndrome (IRIS) was suspected clin-
ically. Unmasking of occult cryptococcal disease was not
detected but could not be excluded.
As shown in Table 3, HIV negative patients with severe
sepsis had significantly lower median platelet counts than
those with sepsis (79  109/L [IQR 43e168] vs 153  109/L
[IQR 98e240] respectively; p < 0.001). Bacteraemia was
identified in 32 (15.0%) of all study patients and eight of
the 32 (25.0%) with severe sepsis. There were 7/213
(3.3%) patients who had culture proven meningitis in addi-
tion to sepsis or severe sepsis. Bacteraemic patients had a
mortality of 25% compared with 21% in those with a nega-
tive blood culture (p Z 0.600). The profile of organisms
was as anticipated from previous studies in Blantyre and
other similar settings, with non-typhoidal Salmonellae
(NTS) and Streptococcus pneumoniae predominating
(Table 3).2,21 Resistance of these common isolates to ceftri-
axone was not observed. Twenty six (12%) patients had a
positive malaria film (1/26 [3.8%] with severe sepsis), but
no deaths were attributed to malaria as no patients with
a positive malaria film died . It was thought clinically
that this was incidental asymptomatic parasitaemia, due
to both the low levels of parasitaemia identified and the
fact that adults in this region have usually developed par-
tial immunity, with severe malaria being predominantly a
disease of childhood.18cteristics of Malawian adults with suspected sepsis.
s Sepsis
n Z 181
Severe
sepsis n Z 32
p*-value
) 105 (58.0) 21 (65.6) 0.272
9) 33 (25e39) 33 (25e39) 0.100a
) 135 (74.6) 26 (81.3) 0.286
) 70 (51.9) 18 (69.2) 0.08
) 58 (43.0) 12 (46.2) 0.464
) 21 (15.6) 7 (26.9) 0.133
e39.4) 38.8 (38.1e39.4) 38.2 (38.0e39.2) 0.056
20) 104 (92e120) 120 (104e140) <0.001a
2) 26 (22e32) 30 (24e38) 0.100a
120) 110 (100e120) 82.5 (80e105) <0.001
14.7 (1.5) 14.2 (2.0) 0.05
6) 94 (90e96) 89 (82e93) <0.001
tween categorical variables and diagnosis.
Table 3 Laboratory characteristics of Malawian adults with suspected sepsis.
Haematology All patients
n Z 213
Sepsis
n Z 181
Severe sepsis n Z 32 p-value
Haemoglobin (g/dl), median (IQR) 10.1(7.4e11.8) 10.4(7.8e11.8) 8.8(6.1e11.3) 0.840
WBC x109/l, median (IQR) 6.1(3.8e10.1) 6.1(3.8e10.1) 5.9(4.2e10.9) 0.990
Blood culturea n/N (%)
Non Typhoidal Salmonella 16/38 (42.1)
Streptococcus pneumoniae 9/38 (23.7)
Cryptococcus neoformans 3/38 (7.9)
Escherichia coli 2/38 (5.3)
Klebsiella spp 2/38 (5.3)
Staphylococcus aureus 1/38 (2.6)
Contaminants 5/38 (13.2)
CSF culturea n/N (%)
Streptococcus pneumoniae 4/41(9.8)
Cryptococcus neoformans 3/41(7.3)
a 1 patient grew Streptococcus pneumoniae in both blood and csf cultures.
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The overall mortality was 46/213 (21.6%) (Table 4), rising to
50% amongst patients with severe sepsis. Most deaths
occurred within the first 10 days. KM survival analysis
demonstrated a similar mortality among severe sepsis cases
in the first five days of admission between HIV positive and
negative patients, with worse outcomes subsequent to this
in the HIV infected subset (Fig. 2). The mortality amongst
adults with severe sepsis co-infected with HIV was 53.8%
(14/26) compared to 33.3% (2/6) in those who were HIV un-
infected. HIV positive sepsis patients who had started ART
within the last 90 days had a higher hazard of death than
those on ART for greater than 90 days (Hazard
ratio Z 2.6, 95% CI [1.01e6.8], p Z 0.049). A statistically
significant difference in death rates according to duration
on ART was not found on analysis of the severe sepsis
subset alone which may relate to the small numbers of pa-
tients. Rates of severe sepsis or mortality did not differ
significantly between those on ART less than 90 days and
ART naive HIV positive patients, odds ratio Z 0.9, 95% CITable 4 In-hospital mortality amongst Malawian adults with su
All patients
n Z 213
S
n
Total Deaths, n (%) 46/213 (21.6) 3
Deaths by 48 h, n (%) 13/213 (6.1)
Mortality HIV neg, n (%) 7/52 (13.5)
Mortality HIVþ, not on ART, n
(%)
21/91 (23.1)
Mortality HIVþ, on ART >90
days, n (%)
7/42 (16.7)
Mortality HIVþ, on ART <90
days, n (%)
11/28 (39.3)
a Fishers exact test.(0.3e2.6), p Z 0.832 and HR Z 0.7, 95% CI (0.3e1.7),
p Z 0.471 respectively. Conversely, treatment with ART
for more than 90 days was associated with a reduced mor-
tality to the extent that no significant difference remained
when compared to HIV negative patients (HRZ 0.8, 95% CI
[0.3e2.4], p Z 0.735).
Independent predictors of severe sepsis included male
sex, decreased temperature, reduced GCS, reduced hae-
moglobin and increased respiratory rate (Table 5). Risk of
death increased significantly with increasing number of
sepsis criteria present, although this association did not
hold for the severe sepsis criteria. On multivariate analysis,
independent risk factors for death were reduced systolic
blood pressure, reduced percentage oxygen saturation,
lower haemoglobin and male sex (Table 6).Discussion
Bloodstream infection (BSI) is known to account for a
considerable burden of morbidity and mortality in resourcespected sepsis.
epsis
Z 181
Severe sepsis n Z 32 ap-value
0/181 (16.6) 16/32 (50.0) <0.001
8/181 (4.4) 5/32 (15.6) 0.014
5/46 (10.9) 2/6 (33.3) 0.180
13/77 (16.9) 8/14 (57.1) 0.003
6/37 (16.2) 1/5 (20.0) 0.618
6/21 (28.6) 5/7 (71.4) 0.060
Figure 2 KaplaneMeier survival curve of patients with
confirmed severe sepsis. Comparison between HIV positive
and HIV negative patients.
Table 6 Multivariate analysis: Independent predictors of
inpatient mortality for all patients with sepsis.
Risk factor Odds ratio 95% confidence
interval
Male sex 2.2 1.04ae4.5
SpO2<90% on room air 2.5 1.1e5.4
Systolic BP < 90 mmHg 6.0 2.0e18.5
Hb g/dl 0.8 0.7e0.9
a Not rounded because it is significant, and inference changes
when rounded.
16 P.I. Waitt et al.constrained, high HIV prevalence countries.22 However suc-
cessful treatment of BSI requires an ability to immediately
recognise and empirically treat the clinical syndromes of
sepsis and severe sepsis. Testing of interventions aimed at
early empirical management of sepsis is limited by a lack
of validated criteria for making syndromic diagnosis of
sepsis in these settings. Here we show that using a modifi-
cation of international criteria,6,8,23,24 amongst adults
with a clinical suspicion of severe infection, patients with
a diagnosis of sepsis, and those at highest risk of death,
can be identified. Reduced systolic blood pressure, reduced
percentage oxygen saturation and a low haemoglobin were
independent risk factors for death amongst the whole
cohort, with male sex, decreased temperature, reduced
GCS, reduced haemoglobin and increased respiratory rate
being predictive of severe sepsis; prospective validation
of these factors, which are line with observations made in
a similar adult population in Uganda,4 may enable develop-
ment of a locally applicable risk stratification tool.
We found that the mortality from severe sepsis was 50%
compared with 17% for patients with sepsis. This mortality
is higher than that reported from industrialised countriesTable 5 Multivariate analysis: independent predictors of
diagnosis of severe sepsis.
Risk factor Odds ratio
for severe
sepsis
95% confidence
interval
Male sex 2.9 1.2e7.1
Temperature <38 C 3.2 1.2e8.3
Glasgow Coma Scale<15 14.2 3.4e60.3
Hb (g/dl)
(per unit decrease)
1.3 1.1e1.4
Respiratory
rate > 20
breaths/min)
7.0 1.4e34.8where critically ill patients are predominantly treated in
intensive care units12,25 and is likely to have been even
higher had we had access to outcome data at 30 days.4
Almost two thirds of the cohort presented with sepsis as
their index presentation for HIV and notably, most of the
patients with known positive HIV status were already on
ART. Having been on ART for more than 90 days reduced
mortality by almost two thirds compared with those who
had commenced treatment more recently; of these, two
thirds of those with sepsis, and three quarters of those
with severe sepsis died, a mortality rate similar to that of
their ART naive counterparts. This is likely to have a consid-
erable impact in Malawi and in similar countries. Malawi has
an estimated national HIV seroprevalence of 12%26 and
since 2004, has benefitted from large scale antiretroviral
therapy (ART) rollout, together with widespread implemen-
tation of cotrimoxazole prophylaxis.27 By the end of 2009,
271,105 HIV-infected individuals had been registered on
the national ART programme of whom 73% remained alive
and on treatment.28 Nonetheless our data suggest that in
addition to the time needed for immune restitution, sepsis
contribute to this adverse outcome, in addition to intercur-
rent malnutrition and anaemia,29 and unmasking of under-
lying TB.30 Previous studies in Malawi have demonstrated
superadded bacterial infections to be a major cause of
death during the initial two months of TB therapy and
that septic patients with Mycobacterium tuberculosis bac-
teraemia have a high in-hospital mortality.31e34Thus myco-
bacterial infection may have contributed to a poor outcome
in our cohort but were unable to determine this with any
certainty.
Optimal management of these septic HIV positive pa-
tients therefore requires specific interventions including
early initiation of ART, e real-time diagnosis of both
pulmonary and disseminated TB, nutritional support, and
prophylaxis against opportunistic infection. Our data
further emphasise the survival benefits of HIV diagnosis
and introduction of ART at the earliest appropriate
opportunity.
Together with previous studies,4 our data show that
well-recognised diagnostic criteria for severe sepsis iden-
tify patients at high risk of death. Such criteria may have
benefit as inclusion criteria for clinical trials of simple
cost-effective interventions based on WHO guidelines.
Only thrombocytopenia as a marker of severe sepsis in
the context of HIV15,16 and falling CD4 counts35 are likely
to have limited utility. Although guidelines developed in
high income countries define the standard of care for
Severe sepsis in Malawian adults 17severe sepsis patients, these do not address the operational
realities of providing health care with constrained re-
sources or use evidence from these settings.11 African hos-
pitals are less likely to have ICUs, appropriate drugs, access
to supplemental oxygen and monitoring equipment and or
adequate human resources,36 and the need to develop solu-
tions pertinent to such clinical settings is pressing. Further-
more, the role of fluid replacement and fluid resuscitation
in the management of African children with sepsis has un-
dergone considerable scrutiny following the unexpected
finding of increased mortality in children with sepsis
receiving bolus fluids.37 In a prospective adult severe sepsis
intervention study conducted at two Ugandan hospitals, pa-
tients receiving early monitored management had a 30%
decreased risk of 30-day mortality compared with historical
control patients receiving standard management.21 There is
therefore an urgent need to evaluate currently available in-
terventions, including fluid resuscitation, in the manage-
ment of sepsis in African adults, ideally as part of a goal-
directed bundle of care.21,38,39
Limitations
There are several limitations to our data. This study was
undertaken at a single centre but we maintain that based
on comparability with the limited number of similar studies
from the region (which have largely been single centre) it is
generalizable to other high HIV prevalence settings. Assess-
ment of outcome was only possible in-hospital rather than
the standard 30-day follow-up into the community, which is
likely to have led to an underestimate of mortality. We had
limited access to laboratory investigations including inflam-
matory markers (e.g. no access to CRP or procalcitonin),
CD4 counts and more specific microbiological tests such as
cryptococcal antigen, toxoplasma serology or virology di-
agnostics. Smear-positive tuberculosis should be apparent
using available tests such as sputum microscopy and chest
radiography,32 but in acutely unwell patients diagnosis re-
mains challenging and mycobacterial cultures were not per-
formed. Additionally, although the sepsis and severe sepsis
criteria used identified adults with a high risk of death, we
did not have access to invasive or non-invasive monitoring
techniques to physiologically confirm these diagnoses.
Finally, patients were enrolled with a clinical suspicion of
severe infection and we did not screen all medical admis-
sions for sepsis criteria. We therefore may have missed
potentially eligible subjects. Subsequent studies should
take this into consideration.
Conclusions and recommendations
This study confirms that severe sepsis in a sub-Saharan
Africa setting has high mortality amongst both HIV-infected
and uninfected adults. Establishment on ART confers sig-
nificant survival benefit in the HIV positive subset, and the
high mortality among patients on ART for less than three
months underscores the importance of vigilant clinical
follow-up among this group. Patients at risk of death can
be identified using simple, objectively measurable criteria,
which following validation amongst other populations can
be used to standardise multi-site interventional trials ofsepsis bundles in resource-poor settings. These will enable
the formulation of appropriate evidenced-based local
guidelines and clinical trials for the management of
critically ill adults in sub-Saharan Africa.
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